Back to Search
Start Over
Transcription-independent Induction of ERBB1 through Hypoxia-inducible Factor 2A Provides Cardioprotection during Ischemia and Reperfusion
- Source :
- Anesthesiology
- Publication Year :
- 2020
-
Abstract
- Background During myocardial ischemia, hypoxia-inducible factors are stabilized and provide protection from ischemia and reperfusion injury. Recent studies show that myocyte-specific hypoxia-inducible factor 2A promotes myocardial ischemia tolerance through induction of epidermal growth factor, amphiregulin. Here, the authors hypothesized that hypoxia-inducible factor 2A may enhance epidermal growth factor receptor 1 (ERBB1) expression in the myocardium that could interface between growth factors and its effect on providing tolerance to ischemia and reperfusion injury. Methods Human myocardial tissues were obtained from ischemic heart disease patients and normal control patients to compare ERBB1 expression. Myocyte-specific Hif2a or ErbB1 knockout mice were generated to observe the effect of Hif2a knockdown in regulating ERBB1 expression and to examine the role of ERBB1 during myocardial ischemia and reperfusion injury. Results Initial studies of myocardial tissues from patients with ischemic heart disease showed increased ERBB1 protein (1.12 ± 0.24 vs. 13.01 ± 2.20, P < 0.001). In contrast, ERBB1 transcript was unchanged. Studies using short hairpin RNA repression of Hif2A or Hif2aloxP/loxP Myosin Cre+ mice directly implicated hypoxia-inducible factor 2A in ERBB1 protein induction during hypoxia or after myocardial ischemia, respectively. Repression of RNA-binding protein 4 abolished hypoxia-inducible factor 2A–dependent induction of ERBB1 protein. Moreover, ErbB1loxP/loxP Myosin Cre+ mice experienced larger infarct sizes (22.46 ± 4.06 vs. 46.14 ± 1.81, P < 0.001) and could not be rescued via amphiregulin treatment. Conclusions These findings suggest that hypoxia-inducible factor 2A promotes transcription-independent induction of ERBB1 protein and implicates epidermal growth factor signaling in protection from myocardial ischemia and reperfusion injury. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New
- Subjects :
- Male
medicine.medical_specialty
Transcription, Genetic
Ischemia
Mice, Transgenic
Myocardial Reperfusion Injury
030204 cardiovascular system & hematology
Article
Mice
03 medical and health sciences
0302 clinical medicine
Reperfusion therapy
Amphiregulin
Epidermal growth factor
Internal medicine
Basic Helix-Loop-Helix Transcription Factors
medicine
Animals
Humans
Myocytes, Cardiac
Epidermal growth factor receptor
skin and connective tissue diseases
030304 developmental biology
Cardioprotection
0303 health sciences
biology
business.industry
Myocardium
medicine.disease
body regions
ErbB Receptors
Mice, Inbred C57BL
Anesthesiology and Pain Medicine
Endocrinology
Hypoxia-inducible factors
biology.protein
Female
business
Reperfusion injury
Subjects
Details
- ISSN :
- 14712253
- Database :
- OpenAIRE
- Journal :
- Anesthesiology
- Accession number :
- edsair.doi.dedup.....a6b5b6b662ef90d296403ef0c206c719
- Full Text :
- https://doi.org/10.1097/aln.0000000000003037